-

Veradigm® Network EHR Data is Now Available in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) Format

New delivery format for three integrated electronic health record (EHR) sources to provide delivery flexibility for Veradigm clients

CHICAGO--(BUSINESS WIRE)--Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format. Veradigm Network EHR is a complete statistically deidentified dataset containing three integrated EHR sources. This source dataset is now available in the OMOP CDM version 5.3.1.

Veradigm Network EHR Data contains more than 170 million patients and provides deidentified, real world data from an extensive national population of patients drawn from physician practices using a variety of EHR products. Veradigm Network EHR Data is built from ambulatory EHRs—where most of the care and patient record generation happens in the United States. It is one of the largest EHR data sets available and is designed for research purposes.

“The transformation of Veradigm Network EHR Data into the OMOP data set will facilitate data sales for clients who need the data delivered in OMOP format,” said Stuart Green, Senior Vice President and General Manager of Veradigm. “This new delivery format will provide the flexibility our clients need so they can answer research questions critical to their business.”

The OMOP CDM is an open community data standard, designed to standardize the structure and content of real-world data. Standardized systematic analytics can be applied to the CDM data, enabling efficient analyses and reliable evidence. The OMOP CDM is maintained by the Observational Health Data Sciences and Informatics (OHDSI) collaborative, a multi-stakeholder, inter-disciplinary effort to bring out the value of observational health data through large-scale analytics. OHDSI maintains an open-source library of analytical tools for research and performance measurement using the OMOP CDM.

Veradigm’s Evalytica® platform, a real-world evidence analytics application will now fully integrate with the Veradigm Network EHR OMOP data and enable cost effective, transparent, and efficient analysis of this real-world data. Both internal and external user groups will now be able to use Veradigm Evalytica to build code sets, define re-usable cohorts and conduct analysis on OMOP’d Veradigm Network EHR Data.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

© 2023 Veradigm Inc. and/or its affiliates. All Rights Reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

Veradigm

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

More News From Veradigm

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom